skip to primary navigationskip to content

Fundraising for Royal Papworth Charity - The Heart & Lung Institute -Izzy's bike challenge

Izzy Wilson will cycle 48km every day for 15 days, starting on Wednesday 27th January & finishing on Wednesday 10th February, to try and raise at least £5000 for the new Heart and Lung Research Institute (HLRI) on the Cambridge Biomedical Campus beside Royal Papworth.

Read more

Cambridge BHF 4-year PhD Programme

Applications are invited for the Autumn 2021 intake for the University of Cambridge 4-year PhD programme in cardiovascular research

Read more

Share your experience of care for heart failure during a pandemic

The COVID-19 pandemic and subsequent lockdown has revealed a number of changes in practice and challenges in providing care for patients with heart failure and other long-term conditions during a time when resources are shifted to fighting the infection. Some changes were positive, some less so. We’d like to hear from patients and healthcare providers in primary care and specialist or secondary services.

Read more

Cambridge Heart and Lung Research Institute

We are raising funds to build a dedicated Heart and Lung Research Institute in Cambridge

Read more

Making Industrialists from Cardiorespiratory Research Opportunities

Making Industrialists from Cardiorespiratory Research Opportunities to develop a future generation of entrepreneurs, business leaders and biotechnologists from the medical sciences investigator base of the BHF funded Centre for Cardiovascular Research Excellence (CCRE) and a future new Heart and Lung Research Institute (HLRI), University of Cambridge.

Read more

Spotlight on Research

We have started a new article series to highlight some ongoing research in Cambridge - follow this link to find out more!

Read more

Covid-19

Covid Research at Cambridge Cardiovascular. The British Heart Foundation Centre of Research Excellence is supporting a number of Cambridge Cardiovascular researchers who are involved in COVID-19 research projects and working collaboratively with researchers across the University of Cambridge and at other institutions across the UK.

Read more

Upcoming events

Upcoming events


RSS Feed Latest news

Machine learning models for diagnosing COVID-19 are not yet suitable for clinical use

Mar 23, 2021

Systematic review finds that machine learning models for detecting and diagnosing COVID-19 from medical images have major flaws and biases, making them unsuitable for use in patients. However, researchers have suggested ways to remedy the problem.

Radiomics in stroke medicine: assessing robustness and feasibility for stroke prevention

Feb 11, 2021

A cross-discipline group of researchers, led by MB PhD student Elizabeth Le and PI James Rudd, have published in Nature Scientific Reports the first attempt to determine whether radiomics might be useful for predicting stroke in patients with carotid artery disease. Radiomics refers to the harnessing of information 'hidden' within medical images for diagnostic and prognostic purposes, and is being increasingly used in oncology.

New method developed for ‘up-sizing’ mini organs used in medical research

Feb 09, 2021

A team of engineers and scientists has developed a method of ‘up-sizing’ organoids: miniature collections of cells which mimic the behaviour of various organs and are promising tools for the study of human biology and disease.

When Symptoms Don't Stop

Jan 22, 2021

Treating those most severely affected by COVID-19 has necessarily taken priority during the pandemic. But could long COVID be the next wave of the crisis?

Our hearts and minds are more closely linked than we thought, suggests University of Cambridge study

Dec 26, 2020

Professor Emanuele Di Angelantonio, BHF-funded researcher at the University of Cambridge, said: “This is the largest evidence to date that feelings related to depression are associated with a person’s chance of having heart disease or stroke in the future.

SIRT6 Protects Smooth Muscle Cells from Senescence and Reduces Atherosclerosis

Dec 23, 2020

SIRT6 protein expression is reduced in human and mouse plaque VSMCs and is positively regulated by CHIP. SIRT6 regulates telomere maintenance and VSMC lifespan, and inhibits atherogenesis, all dependent on its deacetylase activity. Our data shows that endogenous SIRT6 deacetylase is an important and unrecognized inhibitor of VSMC senescence and atherosclerosis.

View all news

Cambridge Cardiovascular logo - transparent

Logo design by Dr Ana-Mishel Spiroski and Dr Sarah Morgan.

 

We connect cardiovascular researchers in Cambridge.

Please follow us on Twitter for local news about research, events, funding calls, and open positions.

For inquiries about our research or the website, please contact Dr Tammy Dougan